Thus, to examine if the effects of treatment with tofacitinib and budesonide could be altered by inflammatory stimuli, TNF and Poly(I:C) was used to mimic a central IBD cytokine and PPR ligand. The gene discussed is TNF; the disease is inflammatory bowel disease.